COVID-19 has made pharma sector sit up and notice deficiencies in their distribution chains Read more
Ratan Tata invests in 18-year-old’s Generic Aadhaar to bring affordable medicines to masses Read more
Disappointed over negative reports about our products in India: Chinese suppliers of rapid test kits Read more